Jefferies Financial Group Trims Recursion Pharmaceuticals (NASDAQ:RXRX) Target Price to $6.00

Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) had its price target trimmed by Jefferies Financial Group from $8.00 to $6.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a hold rating on the stock. RXRX has been the topic of several other reports. Needham & Company LLC dropped their […]